Search

Nami Joseph H Mccarty

from Houston, TX
Age ~54
Get Report
Also known as:
Nami Joseph Mccarty, Nami C Mccarty, Mccarty Nami, Nami S Cho, Cho Nami, Yanping Zhang, Mc Nami, Nami Mc Carty, Nami Mc, Nami Mcarty
Phone and address:
2828 W Holcombe Blvd, Houston, TX 77025
(713) 664-7138
Related to:
Greg M Mccourt, 63
Connected to:
Adalyn R Mccarty, 27Aidan D Mccarty, 27Berretta D Mccarty, 36Bonnie J Mccarty, 80Bonny L Mccarty, 62Breanna N Mccarty, 31Bronshay Mccarty, 49Brooklyn S Mccarty, 37Burke R Mccarty, 33Caleb A Mccarty, 29

Nami Mccarty Phones & Addresses

  • 2828 W Holcombe Blvd, Houston, TX 77025 (713) 664-7138
  • 4226 Judson Ave, Houston, TX 77005
  • Cambridge, MA
  • Somerville, MA
  • Lafayette, IN
  • Belmont, MA
  • Brookline, MA
  • Chapel Hill, NC
  • Carrboro, NC

Work

Company: University of texas-health science center Position: Assistant professor

Education

School / High School: Ph.D.

Industries

Think Tanks

Resumes

Resumes

Nami Mccarty Photo 1

Assistant Professor

View page
Location:
Houston, TX
Industry:
Think Tanks
Work:
University of Texas-Health Science Center
Assistant professor
Education:
Ph.D.

Publications

Us Patents

Regulation Of Mink In Thymocytes And T Lymphocytes

View page
US Patent:
8197817, Jun 12, 2012
Filed:
Dec 16, 2005
Appl. No.:
11/792790
Inventors:
Harvey Cantor - Wellesley MA, US
Nami McCarty - Houston TX, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 39/00
C12N 5/02
G01N 33/567
US Classification:
4241841, 435375, 435 721
Abstract:
The invention relates to compositions and methods used to assess and alter the expression and activity of MINK in cells of the immune system, particularly thymocytes and T lymphocytes. The methods and compositions are used in a variety of clinical applications including vaccination, treatment of cancer, infectious disease, allergy, and transplantation. Screening methods are provided to identify inhibitors of MINK and susceptibility to effects of under- or over-expression of MINK.

Monoclonal Antibodies Specific For Neoplasia-Specific Nadh:disulfide Reductase

View page
US Patent:
20030170757, Sep 11, 2003
Filed:
Feb 24, 2003
Appl. No.:
10/373579
Inventors:
D. Morre - West Lafayette IN, US
NaMi McCarty - Cambridge MA, US
Dorothy Morre - West Lafayette IN, US
Pin-Ju Chueh - West Lafayette IN, US
International Classification:
G01N033/574
C07K016/40
US Classification:
435/007230, 530/388260
Abstract:
Compositions and methods for diagnosis of neoplastic tissue are described. Monoclonal antibodies which specifically recognize the tumor cell specific NADH:protein thiol reductase and the hybridoma cell lines which produce them are provided. Also provided are diagnostic and immunohistological assays for the identification of cells that are neoplastic. Because the antibodies specifically prevent the growth of cancer cells, induce apoptotic cell death of cancer cells, and are without effect on normal cells, the described monoclonal antibodies are useful for inhibiting cancer cell growth and for treating a neoplastic condition.
Control profile
Nami Joseph H Mccarty from Houston, TX, age ~54 Get Report